醫(yī)學(xué)全在線
醫(yī)學(xué)全在線首頁(yè)-醫(yī)師-藥師-護(hù)士-衛(wèi)生資格-高級(jí)職稱-考試題庫(kù)-網(wǎng)校-考研-圖譜-下載-招聘  
分類
國(guó)家級(jí)省級(jí)浙江省各省雜志
科技核心北大核心CSCDCSCD擴(kuò)展
工具
期刊知識(shí)寫作指導(dǎo) 論文投稿推薦期刊
期刊驗(yàn)證論文檢測(cè) 錄用通知往期目錄
SCI
SCI指導(dǎo)影響因子
期刊點(diǎn)評(píng)基金動(dòng)態(tài)
其它
經(jīng)濟(jì)教育計(jì)算機(jī)
建筑體育農(nóng)業(yè)
北京|天津|河北|山西|湖北|江蘇|安徽|山東|上海|浙江|江西|福建|湖南|寧夏|內(nèi)蒙古|河南
四川|重慶|貴州|云南|遼寧|吉林|廣東|廣西|海南|陜西|甘肅|新疆|青海|衛(wèi)生部直屬|黑龍江|兵團(tuán)
您現(xiàn)在的位置: 醫(yī)學(xué)全在線 > 醫(yī)學(xué)論文 > 論文投稿 > 正文:醫(yī)學(xué)論文范文:rAAV2/1Acrp30對(duì)動(dòng)脈粥樣硬化的GK大鼠NFκB及黏附分子的影響
    

醫(yī)學(xué)論文范文:rAAV2/1Acrp30對(duì)動(dòng)脈粥樣硬化的GK大鼠NFκB及黏附分子的影響

來源:本站原創(chuàng) 更新:2013-9-24 論文投稿平臺(tái)

醫(yī)學(xué)論文范文:rAAV2/1Acrp30對(duì)動(dòng)脈粥樣硬化的GK大鼠NFκB及黏附分子的影響

【摘要】 目的 觀察rAAV2/1Acrp30對(duì)動(dòng)脈粥樣硬化GK大鼠模型血清可溶性細(xì)胞間黏附分子(sICAM1)、可溶性血管內(nèi)皮黏附分子(sVCAM1)水平和NFκB表達(dá)的影響,從血管炎癥的角度探討脂聯(lián)素對(duì)糖尿病大血管病變的作用。方法 將造模成功的30只動(dòng)脈粥樣硬化的GK大鼠分為三個(gè)處理組:①模型1組,后肢肌肉注射鹽水;②模型2組,后肢肌肉注射空病毒rAAV2/1;③治療組,后肢肌肉注射 rAAV2/1Acrp30。治療8周后處死所有大鼠,比較三組之間血清sICAM1,sVCAM1及主動(dòng)脈處NFκBp65 mRNA的表達(dá)水平。結(jié)果 治療組和模型1組、模型2組比較,血清sVCAM1、sICAM1顯著降低(P<0.05)。治療組和模型1組、模型2組比較,主動(dòng)脈NFκBp65 mRNA表達(dá)顯著下調(diào)(P<0.05)。結(jié)論 rAAV2/1Acrp30可通過抑制NFκB的表達(dá),減輕炎癥反應(yīng)而對(duì)糖尿病大血管病變產(chǎn)生保護(hù)作用。

【關(guān)鍵詞】 脂聯(lián)素;2型糖尿病大血管病變;核轉(zhuǎn)錄因子;可溶性細(xì)胞間黏附分子;可溶性血管內(nèi)皮黏附分子

Effects of rAAV2/1Acrp30 on NFκB and adhesion molecule

in GK rats with atherosclerosisZHONG Huiju1, ZHANG Ying1, LI Qiangxiang2, LI Guo1

(1. Department of Endocrinology, Xiangya Hospital, Central South University, Changsha 410008;

2. Institute of Political Science and Administration, Central South University, Changsha 410083, China)ABSTRACT: Objective To study the effects of rAAV2/1Acrp30 on sICAM1 and sVCAM1 level as well as NFκB expression in GK rats with diabetic arteriosclerosis so as to explore the effect of adiponectin on diabetic macroangiopathy. Methods A total number of 30 atherosclerotic GK rat models were randomly divided into three groups: ① Model group one (M1): hind limb intramuscular injection of normal saline; ② Model group two (M2): hind limb intramuscular injection of vacuity virus rAAV2/1; ③ Treatment group (T): hind limb intramuscular injection of rAAV2/1-Acrp30 at a dose of 1×1012mg/L. After 8 weeks treatment, the rats were killed, and serum sVCAM1 and sICAM1 level as well as aortic NFκBp65mRNA expression were measured in each group. Aortic NFκBp65mRNA expression was measured by RTPCR.Results Compared with those in control model groups (M1 and M2), sVCAM1 and sICAM1 levels were decreased significantly in the treatment (T) group (P<0.05). Aortic NFκBp65 mRNA expression was significantly downregulated in the treatment (T) group compared with that in control model groups (M1 and M2) (P<0.05). Conclusion rAAV2/1Acrp30 may produce protective effects on diabetic atherosclerosis by decreasing inflammatory reactions醫(yī).學(xué)全.在.線網(wǎng)站m.quanxiangyun.cn.

KEY WORDS: adiponectin; diabetic macroangiopathy; nuclear factorκB (NFκB); soluble intercellular adhesion molecule (sICAM1); soluble vascular cell adhesion molecule (sVCAM1)

炎癥發(fā)病學(xué)說是近年來2型糖尿病病因與發(fā)病機(jī)制的重大進(jìn)展。該學(xué)說認(rèn)為:炎癥反應(yīng)在2型糖尿病及大血管病變的發(fā)生、發(fā)展中具有重要作用。核因子NFκB(nuclear factor)是調(diào)控基因轉(zhuǎn)錄的重要因子,它可與許多蛋白質(zhì)基因啟動(dòng)子和增強(qiáng)子部位的κB序列結(jié)合,誘導(dǎo)這些蛋白表達(dá)增強(qiáng),從而參與炎癥反應(yīng)及動(dòng)脈粥樣硬化等多種疾病的病理過程。NFκB的活化會(huì)極大的刺激炎癥因子如血管細(xì)胞黏附分子1(vascular cell adhesion molecule1, VCAM1)、細(xì)胞間黏附分子1(intracellular adhesion molecule1, ICAM1)、E選擇素(Eselectin)等細(xì)胞黏附分子的轉(zhuǎn)錄與表達(dá)。上述細(xì)胞因子的增多可趨使單核巨噬細(xì)胞、淋巴細(xì)胞的侵入和聚集在動(dòng)脈內(nèi)膜下,內(nèi)膜下的細(xì)胞活化后可合成及分泌前炎癥介質(zhì)如白介素6、白介素8、腫瘤壞死因子(tumor necrosis factor, TNFα)等[1]。NFκB是動(dòng)脈粥樣硬化前炎癥介質(zhì)、炎癥因子和炎癥產(chǎn)物的中樞調(diào)節(jié)者[2]。


[1] [2] [3] [4] 下一頁(yè)

...
關(guān)于我們 - 聯(lián)系我們 -版權(quán)申明 -誠(chéng)聘英才 - 網(wǎng)站地圖 - 網(wǎng)絡(luò)課程 - 幫助
醫(yī)學(xué)全在線 版權(quán)所有© CopyRight 2006-2046, MED126.COM, All Rights Reserved
浙ICP備12017320號(hào)
百度大聯(lián)盟認(rèn)證綠色會(huì)員實(shí)名網(wǎng)站 360認(rèn)證可信網(wǎng)站 中網(wǎng)驗(yàn)證